| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 19,039 | 20,489 | 28,307 | 47,468 | | Cost of Revenue | 13,788 | 15,269 | 19,765 | 30,918 | | | Gross Profit | 5,251 | 5,220 | 8,542 | 16,550 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,200 | 7,518 | 8,029 | 10,930 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,949) | (2,298) | 513 | 5,620 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 172 | 1,814 | 59 | (1,077) | | Earnings Before Interest And Taxes | (1,777) | (484) | 572 | 4,555 | | Interest Expense | 6 | 4 | 23 | 17 | | Income Before Tax | (1,783) | (488) | 549 | 4,538 | | Income Tax Expense | (552) | (207) | 195 | 1,116 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,231) | (281) | 354 | 3,422 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,231) | (281) | 354 | 3,422 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,231) | ($281) | $354 | $3,422 |
|
0.51% Nasdaq 
0.12 (0.82%) 
Income Statement
